JAN 04, 2017 6:30 PM PST

Scientists Unveil Unique Factors Contributing to Autoimmune Disease

WRITTEN BY: Kara Marker

Many autoimmune diseases come in waves, where symptoms temporarily get worse followed by a time of little to no signs of disease. There are a lot of factors that govern why and how an autoimmune disorder occurs, but a recent study was focused specifically on the quality of autoimmunity that causes flare-ups of disease. The same study ultimately resulted in the revealing of two key factors involved in this process, providing doctors and patients new hope for an autoimmune treatment.

Source: OnlineHealth.wiki

From the Schepens Eye Research Institute of Massachusetts Eye and Ear Infirmary, researchers focused on a mouse model of dry eye disease, an autoimmune disease that shares molecular similarities with multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease, and another chronic inflammatory eye disorder called uveitis. The common denominator is Th17 cells, which can continue living in the circulation for a relatively long time as memory cells.

They quickly identified interleukins (IL) 7 and 15, immune cytokines secreted by other immune cells that act as cell-signaling proteins. IL-7 and IL-15 play the role of memory regulation for Th17 cells, the researchers discovered. This enlightenment meant two new targets for treatments.

"By selectively targeting the production and expression of IL-7 and IL-15, we may be able to prevent the development of chronic autoimmune disorders,” explained senior author Reza Dana, MD, Msc, MPH. Dana’s study is the first to uncover how Th17 cells maintain memory.

During the study, when scientists neutralized IL-7 and IL-15, the result was a significant decrease in the number of memory Th17 cells, further highlighting the potential for the two interleukins as targets for a new autoimmune disease treatment.

"In the case of dry eye disease, many of the treatments are showing limited efficacy in patients that do not have a highly inflamed eye," Dana said. "Targeting the chronic, immune nature of autoimmune diseases may be a better strategy for controlling these conditions."

Dana’s study was recently published in the Journal of Autoimmunity.

Source: Massachusetts Eye and Ear Infirmary

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 25, 2021
Immunology
The Immune System Impairs Antibiotic Effectiveness
MAR 25, 2021
The Immune System Impairs Antibiotic Effectiveness
Nitric oxide, a molecule produced by the immune system, can negatively impact antibiotics’ effectiveness, says a s ...
APR 01, 2021
Immunology
Tumor-Killing 101: Vaccine Trains Immune Cells to Keep Skin Cancer at Bay
APR 01, 2021
Tumor-Killing 101: Vaccine Trains Immune Cells to Keep Skin Cancer at Bay
Cancer researchers have developed a therapeutic vaccine for melanoma, a deadly form of skin cancer. Instead of protectin ...
APR 03, 2021
Cancer
New factor plays a key role in immune response
APR 03, 2021
New factor plays a key role in immune response
In a study published recently in Science Immunology, WEHI’s Professor Stephen Nutt, Dr. Michael Chopin, and Mr. Sh ...
APR 21, 2021
Immunology
Human T Cells Can't Recognize COVID Mutants
APR 21, 2021
Human T Cells Can't Recognize COVID Mutants
Genetic variants of the SARS-CoV-2 virus have emerged and tightened their grip on global communities as the pandemic rag ...
APR 29, 2021
Immunology
A Week for World Immunization
APR 29, 2021
A Week for World Immunization
The World Health Organization (WHO) is calling our attention to World Immunization Week, which comes in the last week of ...
MAY 31, 2021
Immunology
Engineering Faster, More Agile T Cell Cancer Fighters
MAY 31, 2021
Engineering Faster, More Agile T Cell Cancer Fighters
Cell therapies use engineered T cells extracted from the patient’s own immune system to rally an attack on tumors. ...
Loading Comments...